FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Granules Pharmaceuticals Trazodone Hydrochloride Recall

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granul…

Granules Pharmaceuticals Inc. · Chantilly, VA

Risk level
Class II
Reported by FDA
Feb 11, 2026
Recall ID
D-0305-2026
Check your lot numberHow we source this data

Summary

Granules Pharmaceuticals recalled Trazodone Hydrochloride starting Jan 26, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0305-2026 on Feb 11, 2026. Reason: Presence of Foreign Tablets/Capsules. Status: Ongoing.

Why it was recalled

Presence of Foreign Tablets/Capsules

Product description

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.

Lot numbers, UPCs & expiration codes

Batch # 6160008A, Exp Date: 12/31/2026

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0305-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jan 26, 2026
FDA report date
Feb 11, 2026
Quantity
71424 bottles.
Recall type
Voluntary: Firm initiated
Recalling firm
Granules Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0305-2026, exactly as published.

Show all FDA fields
City
Chantilly
State
VA
Status
Ongoing
Country
United States
Event ID
98345
Address
3701 Concorde Pkwy
Code information
Batch # 6160008A, Exp Date: 12/31/2026
Postal code
20151-1126
Report date
Feb 11, 2026
Product type
Drugs
Recall number
D-0305-2026
Classification
Class II
Recalling firm
Granules Pharmaceuticals Inc.
Product quantity
71424 bottles.
Reason for recall
Presence of Foreign Tablets/Capsules
Voluntary / mandated
Voluntary: Firm initiated
Product description
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.
Distribution pattern
US Nationwide.
Recall initiation date
Jan 26, 2026
Center classification date
Feb 11, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0305-2026, published Feb 11, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls